Medical Advisory Board

Composed of leading senior research authorities on rosacea and basic research, the NRS medical advisory board evaluates research study proposals and approves the awarding of research grants. The board members also develop NRS medical scientific policies, and review and edit educational materials developed by the NRS.

Mark Dahl, M.D.
Advisory Board Chairman
Professor Emeritus
Mayo Clinic College of Medicine
Former President, American Academy of Dermatology

Michael Detmar, M.D.
Associate Professor, Dermatology
Harvard Medical School
Professor of Pharmacogenomics
Institute of Pharmaceutical Sciences
Swiss Federal Institute of Technology
Zurich, Switzerland
Leading authority on basic research, genomics and angiogenesis

Lynn Drake, M.D.
Harvard Medical School
Former President, American Academy of Dermatology

Richard Gallo, M.D.
Chief, Division of Dermatology
University of California - San Diego
Leading researcher on rosacea

Alexa Boer Kimball, M.D.
Director, Clinical Unit for
Research Trials in Skin
Harvard Medical School
Leading authority on clinical research

Marian Macsai, M.D.
Professor of Ophthalmology
University of Chicago
Leading expert on ocular rosacea

David Norris, M.D.
Chairman, Dermatology
University of Colorado
Former President, Society for Investigative Dermatology

Richard Odom, M.D.
Professor, Clinical Dermatology
University of California-San Francisco
Former President, American Academy of Dermatology

Frank Powell, M.D.
Consultant Dermatologist
Regional Centre of Dermatology
Mater Misericordiae Hospital
Dublin, Ireland
Leading European authority on rosacea

HONORARY MEMBER

Jonathan Wilkin, M.D.
Former Director of Dermatologic and
Dental Drug Products
U.S. Food and Drug Administration
Leading authority on flushing and rosacea